Cargando…

RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood

AIMS: Studies in children reported an association between increased body mass index (BMI) and risk for developing type 1 diabetes (T1D), but evidence in late adolescence is limited. We recently investigated the association between adolescent BMI and type 2 diabetes in young adulthood (Diabetes Care...

Descripción completa

Detalles Bibliográficos
Autores principales: Twig, Gilad, Zucker, Inbar, Zloof, Yair, Cohen, Yaron, Bardugo, Aya, Tsur, Avishai, Lutski, Miri, Cukierman-Yaffe, Tali, Minsky, Noga, Derazne, Estela, Melzer-Cohen, Cheli, Tzur, Dorit, Pinhas-Hamiel, Orit, Chodick, Gabriel, Raz, Itamar, Gerstein, Hertzel, Tirosh, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627670/
http://dx.doi.org/10.1210/jendso/bvac150.893
_version_ 1784823020835045376
author Twig, Gilad
Zucker, Inbar
Zloof, Yair
Cohen, Yaron
Bardugo, Aya
Tsur, Avishai
Lutski, Miri
Cukierman-Yaffe, Tali
Minsky, Noga
Derazne, Estela
Melzer-Cohen, Cheli
Tzur, Dorit
Pinhas-Hamiel, Orit
Chodick, Gabriel
Raz, Itamar
Gerstein, Hertzel
Tirosh, Amir
author_facet Twig, Gilad
Zucker, Inbar
Zloof, Yair
Cohen, Yaron
Bardugo, Aya
Tsur, Avishai
Lutski, Miri
Cukierman-Yaffe, Tali
Minsky, Noga
Derazne, Estela
Melzer-Cohen, Cheli
Tzur, Dorit
Pinhas-Hamiel, Orit
Chodick, Gabriel
Raz, Itamar
Gerstein, Hertzel
Tirosh, Amir
author_sort Twig, Gilad
collection PubMed
description AIMS: Studies in children reported an association between increased body mass index (BMI) and risk for developing type 1 diabetes (T1D), but evidence in late adolescence is limited. We recently investigated the association between adolescent BMI and type 2 diabetes in young adulthood (Diabetes Care 2020, 43(7): 1487-95) and here we studied on the same cohort the association between late adolescent BMI and incident T1D. METHODS: All Israeli adolescents, ages 16-19, undergoing medical evaluation in preparation for mandatory military conscription between January 1996 and December 2016 were included for analysis unless they had a history of dysglycemia (n=1,462,362; 40% women). Data were linked to information about adult onset of T1D in the Israeli National Diabetes Registry. Weight and height were measured at study entry and BMI was computed and transformed to age- and sex-adjusted BMI percentiles according to US Center for Diseases Control. The definition of T1D was determined based on anti-diabetic drugs and was confirmed for a subpopulation of the cohort to which islet autoantibodies data were available. Cox proportional models were applied, with BMI analyzed both as a categorical and continuous variable. RESULTS: There were 777 incident cases of T1D during 15,810,751 person-years (mean age at diagnosis 25.2±3.9 years). The median follow-up period was 11.2 years (IQR 5.8-16.3), with follow-up length shorter for individuals with a higher BMI. The crude diabetes rate showed a consistent graded increase across BMI groups from underweight to obesity; 3.6 to 8.4 cases per 100,000 person-years, respectively. In a multivariable model adjusted for age, sex and socio-demographic variables, the hazard ratios (HRs) for T1D were 1.05 (95% CI 0.87-1.27) for the 50th–74th BMI percentiles, 1.41 (1.11–1.78) for the 75th–84th BMI percentiles, 1.54 (1.23–1.94) for adolescents with overweight (85th–94th percentiles), and 2.05 (1.58–2.66) for adolescents with obesity (BMI≥95th percentile)(reference group, 5th-49th BMI percentile group). One increment in BMI standard deviation was associated with 25% greater risk for incidence of T1D (HR=1.25, 95%CI 1.17-1.32). when the presence of one or multiple (≥2) islet antibodies was added as a criterion for T1D definition, the HRs among those with adolescent obesity were 2.90 (1.80-4.68) and 3.14 (1.68-5.88) respectively. Results were marginally affected by level of adjustment for sociodemographic background, were similar when analysis was stratified by sex, and also persisted when the study population was limited to adolescents with unimpaired health in order to mitigate confounding by coexisting illness. The fraction of type 1 diabetes attributed to adolescent overweight and obesity (Population attributable risk%; PAR%) was 10.1% (95%CI 6.3%-14.2%). CONCLUSIONS: Adolescent overweight and obesity in apparently healthy adolescents were associated with increased risk for incident type 1 diabetes in early adulthood. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m., Monday, June 13, 2022 1:24 p.m. - 1:30 p.m.
format Online
Article
Text
id pubmed-9627670
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96276702022-11-04 RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood Twig, Gilad Zucker, Inbar Zloof, Yair Cohen, Yaron Bardugo, Aya Tsur, Avishai Lutski, Miri Cukierman-Yaffe, Tali Minsky, Noga Derazne, Estela Melzer-Cohen, Cheli Tzur, Dorit Pinhas-Hamiel, Orit Chodick, Gabriel Raz, Itamar Gerstein, Hertzel Tirosh, Amir J Endocr Soc Diabetes & Glucose Metabolism AIMS: Studies in children reported an association between increased body mass index (BMI) and risk for developing type 1 diabetes (T1D), but evidence in late adolescence is limited. We recently investigated the association between adolescent BMI and type 2 diabetes in young adulthood (Diabetes Care 2020, 43(7): 1487-95) and here we studied on the same cohort the association between late adolescent BMI and incident T1D. METHODS: All Israeli adolescents, ages 16-19, undergoing medical evaluation in preparation for mandatory military conscription between January 1996 and December 2016 were included for analysis unless they had a history of dysglycemia (n=1,462,362; 40% women). Data were linked to information about adult onset of T1D in the Israeli National Diabetes Registry. Weight and height were measured at study entry and BMI was computed and transformed to age- and sex-adjusted BMI percentiles according to US Center for Diseases Control. The definition of T1D was determined based on anti-diabetic drugs and was confirmed for a subpopulation of the cohort to which islet autoantibodies data were available. Cox proportional models were applied, with BMI analyzed both as a categorical and continuous variable. RESULTS: There were 777 incident cases of T1D during 15,810,751 person-years (mean age at diagnosis 25.2±3.9 years). The median follow-up period was 11.2 years (IQR 5.8-16.3), with follow-up length shorter for individuals with a higher BMI. The crude diabetes rate showed a consistent graded increase across BMI groups from underweight to obesity; 3.6 to 8.4 cases per 100,000 person-years, respectively. In a multivariable model adjusted for age, sex and socio-demographic variables, the hazard ratios (HRs) for T1D were 1.05 (95% CI 0.87-1.27) for the 50th–74th BMI percentiles, 1.41 (1.11–1.78) for the 75th–84th BMI percentiles, 1.54 (1.23–1.94) for adolescents with overweight (85th–94th percentiles), and 2.05 (1.58–2.66) for adolescents with obesity (BMI≥95th percentile)(reference group, 5th-49th BMI percentile group). One increment in BMI standard deviation was associated with 25% greater risk for incidence of T1D (HR=1.25, 95%CI 1.17-1.32). when the presence of one or multiple (≥2) islet antibodies was added as a criterion for T1D definition, the HRs among those with adolescent obesity were 2.90 (1.80-4.68) and 3.14 (1.68-5.88) respectively. Results were marginally affected by level of adjustment for sociodemographic background, were similar when analysis was stratified by sex, and also persisted when the study population was limited to adolescents with unimpaired health in order to mitigate confounding by coexisting illness. The fraction of type 1 diabetes attributed to adolescent overweight and obesity (Population attributable risk%; PAR%) was 10.1% (95%CI 6.3%-14.2%). CONCLUSIONS: Adolescent overweight and obesity in apparently healthy adolescents were associated with increased risk for incident type 1 diabetes in early adulthood. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m., Monday, June 13, 2022 1:24 p.m. - 1:30 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9627670/ http://dx.doi.org/10.1210/jendso/bvac150.893 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes & Glucose Metabolism
Twig, Gilad
Zucker, Inbar
Zloof, Yair
Cohen, Yaron
Bardugo, Aya
Tsur, Avishai
Lutski, Miri
Cukierman-Yaffe, Tali
Minsky, Noga
Derazne, Estela
Melzer-Cohen, Cheli
Tzur, Dorit
Pinhas-Hamiel, Orit
Chodick, Gabriel
Raz, Itamar
Gerstein, Hertzel
Tirosh, Amir
RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
title RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
title_full RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
title_fullStr RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
title_full_unstemmed RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
title_short RF28 | PSUN302 Obesity at Late Adolescence and Incident Type 1 Diabetes in Young Adulthood
title_sort rf28 | psun302 obesity at late adolescence and incident type 1 diabetes in young adulthood
topic Diabetes & Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627670/
http://dx.doi.org/10.1210/jendso/bvac150.893
work_keys_str_mv AT twiggilad rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT zuckerinbar rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT zloofyair rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT cohenyaron rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT bardugoaya rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT tsuravishai rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT lutskimiri rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT cukiermanyaffetali rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT minskynoga rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT derazneestela rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT melzercohencheli rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT tzurdorit rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT pinhashamielorit rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT chodickgabriel rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT razitamar rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT gersteinhertzel rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood
AT tiroshamir rf28psun302obesityatlateadolescenceandincidenttype1diabetesinyoungadulthood